Alto Neuroscience, Inc.
Alto Neuroscience, Inc. (ANRO) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ANRO · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Alto Neuroscience, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
ANRO insider buying and selling by quarter
ANRO insider selling · ANRO insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · ANRO ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ANRO executive sell shares · ANRO board member insider trading · ANRO insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 14, 2026 | Etkin Amit PRESIDENT AND CEO · Director | Gift | 400,000 | — | Form 4 |
| Mar 1, 2026 | Etkin Amit PRESIDENT AND CEO · Director | Other | 6,227 | $123K | Form 4 |
| Mar 1, 2026 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER & CBO | Other | 2,806 | $55K | Form 4 |
| Jul 10, 2024 | Savitz Adam CHIEF MEDICAL OFFICER | Purchase | 2,931 | $39K | Form 4 |
| Jul 9, 2024 | Savitz Adam CHIEF MEDICAL OFFICER | Purchase | 1,388 | $18K | Form 4 |
| Jul 9, 2024 | Savitz Adam CHIEF MEDICAL OFFICER | Purchase | 10,681 | $134K | Form 4 |
Etkin Amit
PRESIDENT AND CEO · Director
Date
Mar 1
Shares
6,227
Price
$19.69
Value
$123K
Smith Nicholas Conrad
CHIEF FINANCIAL OFFICER & CBO
Date
Mar 1
Shares
2,806
Price
$19.69
Value
$55K
Savitz Adam
CHIEF MEDICAL OFFICER
Date
Jul 10
Shares
2,931
Price
$13.22
Value
$39K
Savitz Adam
CHIEF MEDICAL OFFICER
Date
Jul 9
Shares
1,388
Price
$13.15
Value
$18K
Savitz Adam
CHIEF MEDICAL OFFICER
Date
Jul 9
Shares
10,681
Price
$12.53
Value
$134K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ANRO insider trading
ANRO insider trades
Alto Neuroscience, Inc. (ANRO) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Etkin Amit (PRESIDENT AND CEO · Director), Smith Nicholas Conrad (CHIEF FINANCIAL OFFICER & CBO). Over the past 12 months, 2 insiders have filed transactions with the SEC. ANRO insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Alto Neuroscience, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ANRO insider trading · 5 questionsThe insiders of Alto Neuroscience, Inc. (ANRO) include executives and directors such as Etkin Amit (PRESIDENT AND CEO · Director), Smith Nicholas Conrad (CHIEF FINANCIAL OFFICER & CBO), among others. Over the past 12 months, 2 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026